Stable cellular senescence is associated with persistent DDR activation

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Fumagalli, Marzia ^a,c   Rossiello, Francesca ^a   Mondello, Chiara ^b   d'Adda di Fagagna, Fabrizio ^a,b  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b CNR   (Italy)

^c TTFactor Srl   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIVISION; CELL LOSS; CELL STRAIN; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA REPAIR; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; NUCLEIC ACID STRUCTURE, METABOLISM AND FUNCTION; AGED; CELL CYCLE; CELL LINE; CYTOLOGY; IONIZING RADIATION; METABOLISM; SIGNAL TRANSDUCTION; TELOMERE; ULTRASTRUCTURE;

BETA GALACTOSIDASE; P16 PROTEIN, HUMAN; TUMOR PROTEIN;

AGED; BETA-GALACTOSIDASE; CELL AGING; CELL CYCLE; CELL LINE; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; FIBROBLASTS; HUMANS; NEOPLASM PROTEINS; RADIATION, IONIZING; SIGNAL TRANSDUCTION; TELOMERE;

EID: 84908635214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110969     Document Type: Article

References (58)

1. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461: 1071-1078.
2. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
3. d'Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8: 512-522.
4. Evan GI, d'Adda di Fagagna F (2009) Cellular senescence: hot or what? Curr Opin Genet Dev 19: 25-31.
5. Fumagalli M, Rossiello F, Clerici M., Barozzi S, Cittaro D, et al. (2012) Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 14: 355-365.
6. Suzuki M, Suzuki K, Kodama S., Watanabe M (2006) Interstitial chromatin alteration causes persistent p53 activation involved in the radiation-induced senescence-like growth arrest. Biochem Biophys Res Commun 340: 145-150.
7. Gorbunova V, Seluanov A, Pereira-Smith OM (2002) Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. The Journal of biological chemistry 277: 38540-38549.
8. de Magalhaes JP, Chainiaux F, Remacle J., Toussaint O (2002) Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin fibroblasts. FEBS Lett 523: 157-162.
9. te Poele RH, Okorokov AL, Jardine L, Cummings J., Joel SP (2002) DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876-1883.
10. Schmitt CA, Fridman JS, Yang M, Lee S., Baranov E, et al. (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346.
11. Rodier F, Coppe JP, Patil C.K., Hoeijmakers WA, Munoz DP, et al. (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11: 973-979.
12. Hewitt G, Jurk D, Marques F.D., Correia-Melo C, Hardy T, et al. (2012) Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 3: 708.
13. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, et al. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198.
14. Herbig U, Jobling WA, Chen B.P., Chen DJ, Sedivy JM (2004) Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21(CIP1), but Not p16(INK4a). Mol Cell 14: 501-513.
15. Zou Y, Sfeir A, Gryaznov S.M., Shay JW, Wright WE (2004) Does a sentinel or a subset of short telomeres determine replicative senescence? Mol Biol Cell 15: 3709-3718.
16. Takai H, Smogorzewska A, de Lange T (2003) DNA damage foci at dysfunctional telomeres. Curr Biol 13: 1549-1556.
17. von Zglinicki T, Saretzki G, Ladhoff J., d'Adda di Fagagna F, Jackson SP (2005) Human cell senescence as a DNA damage response. Mech Ageing Dev 126: 111-117.
18. Serrano M, Lin AW, McCurrach M.E., Beach D., Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
19. Lin AW, Barradas M, Stone J.C., van Aelst L, Serrano M, et al. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12: 3008-3019.
20. Bartkova J, Rezaei N, Liontos M., Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
21. Di Micco R, Fumagalli M, Cicalese A., Piccinin S, Gasparini P, et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
22. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G (2007) The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 21: 43-48.
23. Marusyk A, Wheeler LJ, Mathews C.K., DeGregori J (2007) p53 mediates senescence-like arrest induced by chronic replicational stress. Mol Cell Biol 27: 5336-5351.
24. Johnson DG, Degregori J (2006) Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Curr Mol Med 6: 731-738.
25. Grandori C, Wu KJ, Fernandez P, Ngouenet C., Grim J, et al. (2003) Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev 17: 1569-1574.
26. Moiseeva O, Mallette FA, Mukhopadhyay U.K., Moores A., Ferbeyre G (2006) DNA damage signaling and p53-dependent senescence after prolonged betainterferon stimulation. Mol Biol Cell 17: 1583-1592.
27. Ogrunc M, Di Micco R, Liontos M, Bombardelli L., Mione M, et al. (2014) Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ 21: 998-1012.
28. Janzen V, Forkert R, Fleming H.E., Saito Y., Waring MT, et al. (2006) Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443: 421-426.
29. Krishnamurthy J, Ramsey MR, Ligon K.L., Torrice C., Koh A, et al. (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443: 453-457.
30. Molofsky AV, Slutsky SG, Joseph N.M., He S., Pardal R, et al. (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443: 448-452.
31. Baker DJ, Wijshake T, Tchkonia T., LeBrasseur NK, Childs BG, et al. (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479: 232-236.
32. Sedelnikova OA, Horikawa I, Zimonjic D.B., Popescu NC, Bonner WM, et al. (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 6: 168-170.
33. Herbig U, Ferreira M, Condel L., Carey D, Sedivy JM (2006) Cellular senescence in aging primates. Science 311: 1257.
34. Jeyapalan JC, Ferreira M, Sedivy J.M., Herbig U (2007) Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 128: 36-44.
35. Nijnik A, Woodbine L, Marchetti C., Dawson S, Lambe T, et al. (2007) DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447: 686-690.
36. Rossi DJ, Bryder D, Seita J., Nussenzweig A, Hoeijmakers J, et al. (2007) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447: 725-729.
37. Wang C, Jurk D, Maddick M., Nelson G, Martin-Ruiz C, et al. (2009) DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8: 311-323.
38. Rube CE, Fricke A, Widmann T.A., Furst T., Madry H, et al. (2011) Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PloS one 6: e17487.
39. Suram A, Kaplunov J, Patel P.L., Ruan H., Cerutti A, et al. (2012) Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J.
40. Meier A, Fiegler H, Munoz P., Ellis P, Rigler D, et al. (2007) Spreading of mammalian DNA-damage response factors studied by ChIP-chip at damaged telomeres. Embo J 26: 2707-2718.
41. Falcone G, Mazzola A, Michelini F., Bossi G, Censi F, et al. (2013) Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescence. Aging Cell 12: 312-315.
42. Chen JH, Ozanne SE (2006) Deep senescent human fibroblasts show diminished DNA damage foci but retain checkpoint capacity to oxidative stress. FEBS Lett 580: 6669-6673.
43. Bakkenist CJ, Drissi R, Wu J., Kastan MB, Dome JS (2004) Disappearance of the telomere dysfunction-induced stress response in fully senescent cells. Cancer research 64: 3748-3752.
44. Forsyth NR, Evans AP, Shay J.W., Wright WE (2003) Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell 2: 235-243.
45. Beausejour CM, Krtolica A, Galimi F., Narita M, Lowe SW, et al. (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22: 4212-4222.
46. Britt-Compton B, Wyllie F, Rowson J., Capper R, R E.J., et al. (2009) Telomere dynamics during replicative senescence are not directly modulated by conditions of oxidative stress in IMR90 fibroblast cells. Biogerontology 10: 683-693.
47. Mondello C, Chiesa M, Rebuzzini P., Zongaro S, Verri A, et al. (2003) Karyotype instability and anchorage-independent growth in telomerase-immortalized fibroblasts from two centenarian individuals. Biochem Biophys Res Commun 308: 914-921.
48. Bodnar AG, Ouellette M, Frolkis M., Holt SE, Chiu CP, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
49. Milyavsky M, Shats I, Erez N., Tang X, Senderovich S, et al. (2003) Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res 63: 7147-7157.
50. Ramirez RD, Morales CP, Herbert B.S., Rohde JM, Passons C, et al. (2001) Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 15: 398-403.
51. Drayton S, Peters G (2002) Immortalisation and transformation revisited. Curr Opin Genet Dev 12: 98-104.
52. Herbert BS, Wright WE, Shay JW (2002) p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells. Oncogene 21: 7897-7900.
53. Zdanov S, Debacq-Chainiaux F, Remacle J., Toussaint O (2006) Identification of p38MAPK-dependent genes with changed transcript abundance in H2O2-induced premature senescence of IMR-90 hTERT human fibroblasts. FEBS Lett 580: 6455-6463.
54. Dankort D, Filenova E, Collado M., Serrano M, Jones K, et al. (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21: 379-384.
55. Lazzerini Denchi E, Attwooll C, Pasini D., Helin K (2005) Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Molecular and cellular biology 25: 2660-2672.
56. Michaloglou C, Vredeveld LC, Soengas M.S., Denoyelle C., Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
57. Narita M, Nunez S, Heard E., Lin AW, Hearn SA, et al. (2003) Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence. Cell 113: 703-716.
58. Di Micco R, Sulli G, Dobreva M., Liontos M, Botrugno OA, et al. (2011) Interplay between oncogene-induced DNA damage response and heterochro-matin in senescence and cancer. Nat Cell Biol 13: 292-302.